That signal is preclinical only : Dihexa has never entered a human clinical trial, several of the foundational mechanism papers were retracted in 2025 for falsified/fabricated data [4] , and everything below reflects animal reference data and community conventions provided strictly for research and educational reference not medical advice or a recommendation to self-administer
PubMed Comparison decision path KPV vs BPC-157 for Gut Healing: Anti-Inflammatory vs Repair should help you decide which option deserves a clinical review, not force a one-size answer
BPC-157 and TB-500 are mechanistically distinct compounds
Mol Psychiatry 26 , 37013722 (2021)
Thus, blocking amino acid transporters or depleting amino acids such as L-asparaginase may be effective therapeutic strategies to overcome resistance to glutamine withdrawal
From B12 injections to personalized weight loss plans, we're here to support you every step of the way